Relpax 40 mg/1 (Eletriptan Hydrobromide TABLET, FILM COATED) 40 mg/1

Relpax 40 mg is a medication containing eletriptan hydrobromide, used for managing migraine headaches. This oral tablet is designed to provide relief from migraine symptoms. Learn more about its uses and effects.

Strength

40 mg/1

Pack Size

12 BLISTER PACK in 1 CARTON (0049-2340-05) / 1 TABLET, FILM COATED in 1 BLISTER PACK (0049-2340-79)

Manufacturer / TM Owner

ROERIG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Relpax 40 mg is commonly used for the acute treatment of migraine headaches with or without aura in adults. Eletriptan hydrobromide, the active ingredient, works by narrowing blood vessels in the head, which can help alleviate migraine pain. People often wonder, 'What is Relpax used for?' and the primary use is for migraine relief.

Side Effects

Common effects of Relpax 40 mg may include dizziness, drowsiness, and nausea. Some users might experience fatigue or dry mouth. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Precautions & Warnings

Relpax 40 mg should be handled with care. It is important to follow the guidance of a healthcare professional regarding its use. Avoid driving or operating heavy machinery if you experience drowsiness. Store the medication in a cool, dry place away from direct sunlight.

Avoid Interactions

Relpax 40 mg may interact with certain medications, including other migraine treatments, antidepressants, and drugs that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while using this medication.

Frequently Asked Questions

Relpax 40 mg is primarily used for the acute treatment of migraine headaches in adults.

Relpax 40 mg is taken orally, typically at the first sign of a migraine. Follow the instructions provided by your healthcare professional.

Common side effects may include dizziness, drowsiness, nausea, fatigue, and dry mouth.

It is important to consult your healthcare provider before taking Relpax 40 mg with other medications to avoid potential interactions.

Store Relpax 40 mg in a cool, dry place away from direct sunlight and out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.